Real-world approaches are superior to RCTs for studying the potential of CBMPs to treat anxiety
RCTs of cannabis-based medicinal products (CBMPs) for anxiety consistently show little evidence of efficacy, yet patient use continues to grow. This editorial argues the discrepancy is largely…
Read the full articleYou might also wanna read
RCTs vs real world evidence: what the Lancet cannabis meta-analysis misses
drugscience.org.uk·15h ago
Metanalytical Madness Over Medical Cannabis: Meta-analysing Poor Research is Uninformative
drugscience.org.uk·1mo ago
Political ideology and party affiliation as determinants of attitudes toward legalization of Marijuana in the United States: Implications for policy conversations
drugscience.org.uk·2mo ago
From Schedule I to III: What the U.S. Cannabis Rescheduling Really Changes
drugscience.org.uk·2mo ago
Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes
clinicaltrials.gov·just now
Comprehensive study finds no link between mobile phones and brain cancer
theconversation.com·2h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.